SCHEMBL19377430

SCHEMBL19377430

CCOc1ccc(Cl)c(C(=O)NC(=O)Nc2ccc(S(=O)(=O)Cc3ccc4c(c3)CNC4)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 1/20 0.46
▸ TAS1R3 Q7RTX0 1/20 0.44
▸ TAS1R1 Q7RTX1 1/20 0.44
▸ GAA P10253 2/20 0.42
▸ MLNR O43193 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ USP28 Q96RU2 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 4/20 0.39
▸ PCTP Q9UKL6 2/20 0.39
▸ KLKB1 P03952 1/20 0.38
▸ LMNA P02545 3/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ HCAR1 Q9BXC0 1/20 0.37
▸ STARD7 Q9NQZ5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377387 0.89 GHSR (0.45) GHSRMLNRUSP28MEN1KMT2A
SCHEMBL19377411 0.87 PCTP (0.47) GHSRTAS1R3TAS1R1GAAALDH1A1
SCHEMBL19377297 0.81 GHSR (0.47) GHSRGAAALDH1A1HTTSMN1; SMN2
SCHEMBL19377110 0.77 DRD2 (0.54) GHSRMLNRALDH1A1USP28MEN1
SCHEMBL19377434 0.76 MMP2 (0.46) GHSRMLNR
SCHEMBL19384137 0.76 MLNR (0.39) MLNRUSP28MEN1KMT2A
SCHEMBL19377316 0.75 NAMPT (0.54) ALDH1A1HTTKDM4ESMN1; SMN2MEN1
SCHEMBL19377184 0.74 NAMPT (0.47) GHSRMLNRALDH1A1HTTKDM4E
SCHEMBL19377261 0.74 CA12 (0.49) GHSRMLNRALDH1A1POLB
SCHEMBL19377651 0.74 MLNR (0.47) GHSRMLNRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR GHSR 2/4885TAS1R3 791/4885TAS1R1 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback